FDA Lifts Hold on Diabetes-Treatment Trials
FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate
Friday, the FDA lifted the clinical hold on Biomea Fusion, Inc.’s (NASDAQ:BMEA) ongoing Phase 1/2 clinical trials of the company’s investigational covalent menin inhibitor BMF-219 in type 2 and type 1 diabetes (COVALENT-111 and COVALENT-112),
US FDA lifts clinical hold on Biomea's diabetes trials after safety review
The U.S. Food and Drug Administration lifted a clinical hold on Biomea Fusion's ongoing studies of its experimental drug for type 1 and type 2 diabetes, the drug developer said on Thursday. The regulator had placed a hold on two trials of its lead drug,
Biomea Fusion : FDA Lifts Clinical Hold On BMF-219 For Type 1 And Type 2 Diabetes Trials; Stock Up
Biomea Fusion Inc. (BMEA) announced that the U.S. Food and Drug Administration has lifted the clinical hold on the company's ongoing
Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials
Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,
US FDA lifts clinical hold on Biomea's diabetes trials
Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,
FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials
We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.
BMEA Stock Up 9% as FDA Lifts Clinical Hold on 2 Diabetes Studies
Shares of Biomea Fusion BMEA gained 9.1% on Thursday after the FDA lifted the clinical hold it had earlier placed on the company’s ongoing early to mid-stage studies evaluating its lead candidate, BMF-219,
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...
mp1st.com4m
New Destiny 2 Trials of Osiris Rewards and Map This Week September 27
MP1st's new Destiny 2 Trials of Osiris rewards and map this week September 27, 2024 post is live now. Read on for the map and ...
The Trump Trials: A motion to rescue
The latest news in Donald Trump’s four criminal cases, including more delays and a mammoth legal filing due on Thursday from ...
OCTC students host Salem Witch Trials exhibit
Students at Owensboro Community and Technical College (OCTC) have pulled together an art exhibit worthy of the Halloween ...
devdiscourse1d
WHO Releases New Guidance to Enhance Clinical Trials and Improve Global Health Equity
Dr. Jeremy Farrar, WHO’s Chief Scientist, emphasized the importance of strengthening country-led R&D and integrating clinical ...
PharmiWeb26m
During European Myeloma Day, MPE highlights the importance of improving access to clinical trials
Today is European Myeloma Day, a date dedicated to raising awareness of key issues affecting myeloma patients across Europe. This year, Myeloma Patients Europe (MPE) is highlighting the role of ...
Dronelife31m
Transgrid Trials Drone Technology for Bushfire Safety and Efficiency
Innovative Approach to Vegetation Management and Network Inspection in NSW and AC Transgrid has launched a new trial using advanced drone technology to inspect its high-voltage transmission network ...
‘Agatha All Along’ Episode 3 Recap: “Through Many Miles of Tricks and Trials”
Boy Kills World’ on Hulu, a Hyperviolent Comix-Meets-Video Games Revenge Flick Starring Bill Sarsgard 'The Penguin' Series ...
Counting Africa In For Clinical Trials
Pharma leaders need to consider the lack of diversity in clinical trial findings and the resulting dearth of therapies ...